nodes	percent_of_prediction	percent_of_DWPC	metapath
Argatroban—F2—malignant glioma	0.815	1	CbGaD
Argatroban—CYP3A4—Temozolomide—malignant glioma	0.0866	1	CbGbCtD
Argatroban—F2—vertebral column—malignant glioma	0.00726	0.448	CbGeAlD
Argatroban—F2—endothelium—malignant glioma	0.00323	0.199	CbGeAlD
Argatroban—F2—blood vessel—malignant glioma	0.00298	0.184	CbGeAlD
Argatroban—Haemorrhage intracranial—Temozolomide—malignant glioma	0.00206	0.0832	CcSEcCtD
Argatroban—Digestion impaired—Temozolomide—malignant glioma	0.00126	0.0511	CcSEcCtD
Argatroban—Thrombosis—Carmustine—malignant glioma	0.00123	0.0499	CcSEcCtD
Argatroban—F2—spinal cord—malignant glioma	0.00101	0.0625	CbGeAlD
Argatroban—Pulmonary embolism—Carmustine—malignant glioma	0.000874	0.0353	CcSEcCtD
Argatroban—Respiratory failure—Temozolomide—malignant glioma	0.00086	0.0348	CcSEcCtD
Argatroban—Pulmonary embolism—Temozolomide—malignant glioma	0.000844	0.0341	CcSEcCtD
Argatroban—F2—central nervous system—malignant glioma	0.000822	0.0507	CbGeAlD
Argatroban—Sepsis—Carmustine—malignant glioma	0.000758	0.0307	CcSEcCtD
Argatroban—Thrombophlebitis—Carmustine—malignant glioma	0.000733	0.0296	CcSEcCtD
Argatroban—Thrombophlebitis—Temozolomide—malignant glioma	0.000708	0.0286	CcSEcCtD
Argatroban—F2—brain—malignant glioma	0.000652	0.0402	CbGeAlD
Argatroban—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.000634	0.0256	CcSEcCtD
Argatroban—Pneumonia—Carmustine—malignant glioma	0.000492	0.0199	CcSEcCtD
Argatroban—Urinary tract infection—Carmustine—malignant glioma	0.000475	0.0192	CcSEcCtD
Argatroban—Pneumonia—Temozolomide—malignant glioma	0.000475	0.0192	CcSEcCtD
Argatroban—Urinary tract infection—Temozolomide—malignant glioma	0.000459	0.0186	CcSEcCtD
Argatroban—Haemoglobin—Carmustine—malignant glioma	0.000441	0.0178	CcSEcCtD
Argatroban—Haemorrhage—Carmustine—malignant glioma	0.000439	0.0177	CcSEcCtD
Argatroban—Haemoglobin—Temozolomide—malignant glioma	0.000426	0.0172	CcSEcCtD
Argatroban—Haemorrhage—Temozolomide—malignant glioma	0.000424	0.0171	CcSEcCtD
Argatroban—Angiopathy—Temozolomide—malignant glioma	0.000385	0.0156	CcSEcCtD
Argatroban—Back pain—Carmustine—malignant glioma	0.000369	0.0149	CcSEcCtD
Argatroban—Back pain—Temozolomide—malignant glioma	0.000357	0.0144	CcSEcCtD
Argatroban—Chest pain—Carmustine—malignant glioma	0.000325	0.0131	CcSEcCtD
Argatroban—Cough—Temozolomide—malignant glioma	0.000322	0.013	CcSEcCtD
Argatroban—Confusional state—Carmustine—malignant glioma	0.000314	0.0127	CcSEcCtD
Argatroban—Infection—Carmustine—malignant glioma	0.00031	0.0125	CcSEcCtD
Argatroban—Tachycardia—Carmustine—malignant glioma	0.000304	0.0123	CcSEcCtD
Argatroban—Confusional state—Temozolomide—malignant glioma	0.000304	0.0123	CcSEcCtD
Argatroban—Infection—Temozolomide—malignant glioma	0.000299	0.0121	CcSEcCtD
Argatroban—Hypotension—Carmustine—malignant glioma	0.000291	0.0118	CcSEcCtD
Argatroban—Dyspnoea—Carmustine—malignant glioma	0.000278	0.0112	CcSEcCtD
Argatroban—Gastrointestinal disorder—Carmustine—malignant glioma	0.000269	0.0109	CcSEcCtD
Argatroban—Dyspnoea—Temozolomide—malignant glioma	0.000269	0.0109	CcSEcCtD
Argatroban—Constipation—Carmustine—malignant glioma	0.000267	0.0108	CcSEcCtD
Argatroban—Pain—Carmustine—malignant glioma	0.000267	0.0108	CcSEcCtD
Argatroban—Dyspepsia—Temozolomide—malignant glioma	0.000265	0.0107	CcSEcCtD
Argatroban—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00026	0.0105	CcSEcCtD
Argatroban—Pain—Temozolomide—malignant glioma	0.000258	0.0104	CcSEcCtD
Argatroban—Constipation—Temozolomide—malignant glioma	0.000258	0.0104	CcSEcCtD
Argatroban—Feeling abnormal—Carmustine—malignant glioma	0.000257	0.0104	CcSEcCtD
Argatroban—Gastrointestinal pain—Carmustine—malignant glioma	0.000255	0.0103	CcSEcCtD
Argatroban—CYP3A4—central nervous system—malignant glioma	0.00025	0.0154	CbGeAlD
Argatroban—Feeling abnormal—Temozolomide—malignant glioma	0.000248	0.01	CcSEcCtD
Argatroban—Abdominal pain—Carmustine—malignant glioma	0.000246	0.00996	CcSEcCtD
Argatroban—Body temperature increased—Carmustine—malignant glioma	0.000246	0.00996	CcSEcCtD
Argatroban—Gastrointestinal pain—Temozolomide—malignant glioma	0.000246	0.00996	CcSEcCtD
Argatroban—Abdominal pain—Temozolomide—malignant glioma	0.000238	0.00963	CcSEcCtD
Argatroban—Body temperature increased—Temozolomide—malignant glioma	0.000238	0.00963	CcSEcCtD
Argatroban—Hypersensitivity—Carmustine—malignant glioma	0.00023	0.00929	CcSEcCtD
Argatroban—Hypersensitivity—Temozolomide—malignant glioma	0.000222	0.00897	CcSEcCtD
Argatroban—Diarrhoea—Carmustine—malignant glioma	0.000213	0.00862	CcSEcCtD
Argatroban—Dizziness—Carmustine—malignant glioma	0.000206	0.00834	CcSEcCtD
Argatroban—Diarrhoea—Temozolomide—malignant glioma	0.000206	0.00833	CcSEcCtD
Argatroban—Dizziness—Temozolomide—malignant glioma	0.000199	0.00806	CcSEcCtD
Argatroban—Vomiting—Carmustine—malignant glioma	0.000198	0.00801	CcSEcCtD
Argatroban—Rash—Carmustine—malignant glioma	0.000197	0.00795	CcSEcCtD
Argatroban—Dermatitis—Carmustine—malignant glioma	0.000196	0.00794	CcSEcCtD
Argatroban—Headache—Carmustine—malignant glioma	0.000195	0.0079	CcSEcCtD
Argatroban—Vomiting—Temozolomide—malignant glioma	0.000191	0.00775	CcSEcCtD
Argatroban—Rash—Temozolomide—malignant glioma	0.00019	0.00768	CcSEcCtD
Argatroban—Dermatitis—Temozolomide—malignant glioma	0.00019	0.00767	CcSEcCtD
Argatroban—Headache—Temozolomide—malignant glioma	0.000189	0.00763	CcSEcCtD
Argatroban—Nausea—Carmustine—malignant glioma	0.000185	0.00749	CcSEcCtD
Argatroban—Nausea—Temozolomide—malignant glioma	0.000179	0.00724	CcSEcCtD
Argatroban—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000176	0.00307	CbGpPWpGaD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—PIK3CA—malignant glioma	0.000172	0.003	CbGpPWpGaD
Argatroban—F2—Hemostasis—ANGPT2—malignant glioma	0.000169	0.00296	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CCR4—malignant glioma	0.000169	0.00295	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—SOD1—malignant glioma	0.000168	0.00294	CbGpPWpGaD
Argatroban—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000166	0.0029	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—IL1B—malignant glioma	0.000165	0.00288	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—CYP2C18—malignant glioma	0.000165	0.00288	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CXCR3—malignant glioma	0.000165	0.00288	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—malignant glioma	0.000164	0.00286	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—XBP1—malignant glioma	0.000163	0.00285	CbGpPWpGaD
Argatroban—F2—Cell surface interactions at the vascular wall—PIK3CB—malignant glioma	0.000163	0.00285	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—CYP2C18—malignant glioma	0.000162	0.00284	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—FN1—malignant glioma	0.00016	0.0028	CbGpPWpGaD
Argatroban—F2—FOXA2 and FOXA3 transcription factor networks—AKT1—malignant glioma	0.000155	0.00271	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—PTK2—malignant glioma	0.000154	0.0027	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—APC—malignant glioma	0.000153	0.00268	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—PIK3CG—malignant glioma	0.000153	0.00268	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—EGF—malignant glioma	0.000152	0.00265	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—TNF—malignant glioma	0.000151	0.00264	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—BDKRB2—malignant glioma	0.000151	0.00263	CbGpPWpGaD
Argatroban—F2—Hemostasis—HIST1H3B—malignant glioma	0.000147	0.00256	CbGpPWpGaD
Argatroban—F2—Hemostasis—MYB—malignant glioma	0.000145	0.00254	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—BRAF—malignant glioma	0.000144	0.00252	CbGpPWpGaD
Argatroban—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000144	0.00252	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—LATS2—malignant glioma	0.000144	0.00252	CbGpPWpGaD
Argatroban—F2—Angiopoietin receptor Tie2-mediated signaling—AKT1—malignant glioma	0.00014	0.00245	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—KNG1—malignant glioma	0.000137	0.00239	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—PIK3CD—malignant glioma	0.000135	0.00236	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—GSTT1—malignant glioma	0.000133	0.00233	CbGpPWpGaD
Argatroban—F2—Folate Metabolism—TP53—malignant glioma	0.000133	0.00232	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—PDGFB—malignant glioma	0.00013	0.00226	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—FGF2—malignant glioma	0.000129	0.00226	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CXCR3—malignant glioma	0.000125	0.00219	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—PTGS1—malignant glioma	0.000125	0.00218	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—SPHK1—malignant glioma	0.000121	0.00212	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—RAF1—malignant glioma	0.00012	0.0021	CbGpPWpGaD
Argatroban—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.00012	0.0021	CbGpPWpGaD
Argatroban—F2—Selenium Micronutrient Network—TNF—malignant glioma	0.00012	0.00209	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—PIK3CB—malignant glioma	0.000118	0.00205	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—FN1—malignant glioma	0.000117	0.00204	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—BDKRB2—malignant glioma	0.000115	0.002	CbGpPWpGaD
Argatroban—F2—Hemostasis—H3F3A—malignant glioma	0.000113	0.00198	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—malignant glioma	0.000112	0.00196	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—PIK3CG—malignant glioma	0.000112	0.00196	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—EGF—malignant glioma	0.000111	0.00193	CbGpPWpGaD
Argatroban—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000109	0.00191	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—LATS1—malignant glioma	0.000109	0.00191	CbGpPWpGaD
Argatroban—F2—Cell surface interactions at the vascular wall—KRAS—malignant glioma	0.000108	0.00189	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—KNG1—malignant glioma	0.000104	0.00182	CbGpPWpGaD
Argatroban—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000103	0.00181	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—AKT2—malignant glioma	0.000102	0.00179	CbGpPWpGaD
Argatroban—F2—Cell surface interactions at the vascular wall—PIK3CA—malignant glioma	9.94e-05	0.00174	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—PIK3CD—malignant glioma	9.84e-05	0.00172	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CCR4—malignant glioma	9.53e-05	0.00167	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—RTEL1—malignant glioma	9.34e-05	0.00163	CbGpPWpGaD
Argatroban—F2—Hemostasis—KNG1—malignant glioma	9.33e-05	0.00163	CbGpPWpGaD
Argatroban—F2—Peptide ligand-binding receptors—CXCL8—malignant glioma	9.3e-05	0.00162	CbGpPWpGaD
Argatroban—CYP3A5—Biological oxidations—GSTP1—malignant glioma	9.24e-05	0.00161	CbGpPWpGaD
Argatroban—F2—Hemostasis—IFNA2—malignant glioma	9.14e-05	0.0016	CbGpPWpGaD
Argatroban—CYP3A5—Metapathway biotransformation—GSTP1—malignant glioma	9.11e-05	0.00159	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—malignant glioma	8.98e-05	0.00157	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	8.83e-05	0.00154	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—RAF1—malignant glioma	8.78e-05	0.00153	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	8.71e-05	0.00152	CbGpPWpGaD
Argatroban—F2—Hemostasis—SOD1—malignant glioma	8.66e-05	0.00151	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CCR4—malignant glioma	8.66e-05	0.00151	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—PIK3CB—malignant glioma	8.58e-05	0.0015	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—BCHE—malignant glioma	8.36e-05	0.00146	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—EGFR—malignant glioma	8.26e-05	0.00144	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—FBXW7—malignant glioma	8.22e-05	0.00144	CbGpPWpGaD
Argatroban—F2—Hemostasis—PTK2—malignant glioma	7.96e-05	0.00139	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—IL2—malignant glioma	7.88e-05	0.00138	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—KRAS—malignant glioma	7.8e-05	0.00136	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	7.66e-05	0.00134	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	7.55e-05	0.00132	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MDK—malignant glioma	7.38e-05	0.00129	CbGpPWpGaD
Argatroban—F2—Regulation of Actin Cytoskeleton—PIK3CA—malignant glioma	7.17e-05	0.00125	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CXCR3—malignant glioma	7.08e-05	0.00124	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—DTX1—malignant glioma	7.04e-05	0.00123	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—VEGFA—malignant glioma	6.69e-05	0.00117	CbGpPWpGaD
Argatroban—F2—Hemostasis—PDGFB—malignant glioma	6.68e-05	0.00117	CbGpPWpGaD
Argatroban—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	6.63e-05	0.00116	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—BDKRB2—malignant glioma	6.48e-05	0.00113	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CXCR3—malignant glioma	6.43e-05	0.00112	CbGpPWpGaD
Argatroban—F2—Hemostasis—CAV1—malignant glioma	6.33e-05	0.00111	CbGpPWpGaD
Argatroban—F2—Class A/1 (Rhodopsin-like receptors)—CXCL8—malignant glioma	6.24e-05	0.00109	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—GSTT1—malignant glioma	6.19e-05	0.00108	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—malignant glioma	6.16e-05	0.00108	CbGpPWpGaD
Argatroban—F2—Hemostasis—FN1—malignant glioma	6.03e-05	0.00105	CbGpPWpGaD
Argatroban—F2—G alpha (q) signalling events—PIK3CA—malignant glioma	5.98e-05	0.00104	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—KNG1—malignant glioma	5.89e-05	0.00103	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—BDKRB2—malignant glioma	5.88e-05	0.00103	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—malignant glioma	5.82e-05	0.00102	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—PTGS1—malignant glioma	5.8e-05	0.00101	CbGpPWpGaD
Argatroban—F2—Hemostasis—PIK3CG—malignant glioma	5.77e-05	0.00101	CbGpPWpGaD
Argatroban—F2—Hemostasis—EGF—malignant glioma	5.7e-05	0.000996	CbGpPWpGaD
Argatroban—F2—Hemostasis—PTPN11—malignant glioma	5.67e-05	0.00099	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SUFU—malignant glioma	5.59e-05	0.000977	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HEY2—malignant glioma	5.52e-05	0.000965	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—GFAP—malignant glioma	5.39e-05	0.000942	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—COX8A—malignant glioma	5.36e-05	0.000937	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—KNG1—malignant glioma	5.35e-05	0.000935	CbGpPWpGaD
Argatroban—F2—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—malignant glioma	5.34e-05	0.000934	CbGpPWpGaD
Argatroban—F2—Hemostasis—AKT2—malignant glioma	5.28e-05	0.000922	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—PIK3CA—malignant glioma	5.23e-05	0.000913	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SPHK1—malignant glioma	5.22e-05	0.000912	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HEY1—malignant glioma	5.11e-05	0.000893	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CCR4—malignant glioma	5.11e-05	0.000893	CbGpPWpGaD
Argatroban—F2—Hemostasis—PIK3CD—malignant glioma	5.07e-05	0.000886	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HIST1H3B—malignant glioma	4.97e-05	0.000868	CbGpPWpGaD
Argatroban—F2—GPCR ligand binding—CXCL8—malignant glioma	4.75e-05	0.00083	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—MMP3—malignant glioma	4.74e-05	0.000828	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—ASMT—malignant glioma	4.56e-05	0.000797	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—JAG2—malignant glioma	4.53e-05	0.000792	CbGpPWpGaD
Argatroban—F2—Hemostasis—RAF1—malignant glioma	4.53e-05	0.000791	CbGpPWpGaD
Argatroban—F2—Hemostasis—PIK3CB—malignant glioma	4.42e-05	0.000772	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—RTEL1—malignant glioma	4.34e-05	0.000758	CbGpPWpGaD
Argatroban—CYP3A4—Biological oxidations—GSTP1—malignant glioma	4.29e-05	0.00075	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—BCAN—malignant glioma	4.29e-05	0.000749	CbGpPWpGaD
Argatroban—F2—Platelet activation, signaling and aggregation—AKT1—malignant glioma	4.27e-05	0.000746	CbGpPWpGaD
Argatroban—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	4.23e-05	0.00074	CbGpPWpGaD
Argatroban—F2—Hemostasis—IL2—malignant glioma	4.06e-05	0.000709	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—MMP2—malignant glioma	4.02e-05	0.000703	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—H3F3A—malignant glioma	3.84e-05	0.00067	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CXCR3—malignant glioma	3.8e-05	0.000664	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—YWHAE—malignant glioma	3.7e-05	0.000646	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NTRK2—malignant glioma	3.7e-05	0.000646	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—FLT1—malignant glioma	3.68e-05	0.000643	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—DUSP6—malignant glioma	3.66e-05	0.00064	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CG—malignant glioma	3.65e-05	0.000637	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—JAG1—malignant glioma	3.62e-05	0.000632	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NOTCH3—malignant glioma	3.6e-05	0.000629	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—FBXW7—malignant glioma	3.54e-05	0.000619	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—BDKRB2—malignant glioma	3.48e-05	0.000607	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—IDH2—malignant glioma	3.46e-05	0.000604	CbGpPWpGaD
Argatroban—F2—Hemostasis—VEGFA—malignant glioma	3.45e-05	0.000603	CbGpPWpGaD
Argatroban—F2—Metabolism of proteins—CXCL8—malignant glioma	3.34e-05	0.000584	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—AKT2—malignant glioma	3.34e-05	0.000583	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CG—malignant glioma	3.31e-05	0.000578	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PTPN11—malignant glioma	3.25e-05	0.000568	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP2B6—malignant glioma	3.25e-05	0.000568	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NOTCH2—malignant glioma	3.23e-05	0.000564	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CD—malignant glioma	3.21e-05	0.00056	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—KNG1—malignant glioma	3.16e-05	0.000552	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—AKT2—malignant glioma	3.03e-05	0.000529	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NTRK1—malignant glioma	3.01e-05	0.000526	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—IDH1—malignant glioma	2.97e-05	0.000519	CbGpPWpGaD
Argatroban—F2—Hemostasis—KRAS—malignant glioma	2.93e-05	0.000512	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CD—malignant glioma	2.91e-05	0.000508	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SPHK1—malignant glioma	2.88e-05	0.000502	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CYP2C18—malignant glioma	2.82e-05	0.000492	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MMP3—malignant glioma	2.8e-05	0.000489	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CB—malignant glioma	2.79e-05	0.000488	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CDKN2B—malignant glioma	2.78e-05	0.000485	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PTK2—malignant glioma	2.7e-05	0.000471	CbGpPWpGaD
Argatroban—F2—Hemostasis—PIK3CA—malignant glioma	2.69e-05	0.000471	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—CXCL8—malignant glioma	2.68e-05	0.000469	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HES1—malignant glioma	2.65e-05	0.000463	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NCOR1—malignant glioma	2.63e-05	0.00046	CbGpPWpGaD
Argatroban—F2—Hemostasis—TP53—malignant glioma	2.61e-05	0.000455	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—RAF1—malignant glioma	2.6e-05	0.000454	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—IL2—malignant glioma	2.57e-05	0.000448	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CB—malignant glioma	2.54e-05	0.000443	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PDGFRA—malignant glioma	2.52e-05	0.000441	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—COX8A—malignant glioma	2.49e-05	0.000436	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—SPP1—malignant glioma	2.45e-05	0.000428	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—CXCL8—malignant glioma	2.44e-05	0.000426	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—IL2—malignant glioma	2.33e-05	0.000407	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TERT—malignant glioma	2.32e-05	0.000406	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTT1—malignant glioma	2.28e-05	0.000398	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PDGFB—malignant glioma	2.27e-05	0.000396	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—FGFR1—malignant glioma	2.25e-05	0.000394	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—HIF1A—malignant glioma	2.22e-05	0.000388	CbGpPWpGaD
Argatroban—F2—Hemostasis—AKT1—malignant glioma	2.2e-05	0.000385	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CAV1—malignant glioma	2.15e-05	0.000375	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PTGS1—malignant glioma	2.14e-05	0.000373	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—KDR—malignant glioma	2.12e-05	0.000371	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—ASMT—malignant glioma	2.12e-05	0.00037	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—FN1—malignant glioma	2.04e-05	0.000357	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—BAD—malignant glioma	2.02e-05	0.000353	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—NOTCH1—malignant glioma	2e-05	0.000349	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—BCAN—malignant glioma	1.99e-05	0.000348	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—BCHE—malignant glioma	1.99e-05	0.000347	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—SLC5A5—malignant glioma	1.96e-05	0.000343	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CD80—malignant glioma	1.96e-05	0.000342	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CG—malignant glioma	1.96e-05	0.000342	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—APC—malignant glioma	1.96e-05	0.000342	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—EGF—malignant glioma	1.93e-05	0.000338	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PTPN11—malignant glioma	1.92e-05	0.000336	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—BRAF—malignant glioma	1.84e-05	0.000321	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—AKT2—malignant glioma	1.79e-05	0.000313	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—EGFR—malignant glioma	1.78e-05	0.000311	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CD—malignant glioma	1.72e-05	0.0003	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—PIK3CA—malignant glioma	1.7e-05	0.000298	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—KRAS—malignant glioma	1.68e-05	0.000294	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—FGF2—malignant glioma	1.65e-05	0.000288	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—IDH2—malignant glioma	1.61e-05	0.000281	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—GSTP1—malignant glioma	1.58e-05	0.000276	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—PIK3CA—malignant glioma	1.55e-05	0.00027	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MDM2—malignant glioma	1.54e-05	0.000269	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CAT—malignant glioma	1.54e-05	0.000268	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—RAF1—malignant glioma	1.54e-05	0.000268	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—ERBB2—malignant glioma	1.52e-05	0.000265	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.51e-05	0.000264	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CB—malignant glioma	1.5e-05	0.000262	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—NCOR1—malignant glioma	1.45e-05	0.000254	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CXCL8—malignant glioma	1.44e-05	0.000252	CbGpPWpGaD
Argatroban—F2—GPCR downstream signaling—AKT1—malignant glioma	1.39e-05	0.000243	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—IDH1—malignant glioma	1.38e-05	0.000241	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—CASP3—malignant glioma	1.38e-05	0.000241	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—IL2—malignant glioma	1.38e-05	0.00024	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SPHK1—malignant glioma	1.34e-05	0.000234	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.31e-05	0.000229	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MMP9—malignant glioma	1.3e-05	0.000228	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PTEN—malignant glioma	1.3e-05	0.000226	CbGpPWpGaD
Argatroban—F2—Signaling by GPCR—AKT1—malignant glioma	1.26e-05	0.000221	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—CAV1—malignant glioma	1.18e-05	0.000207	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—VEGFA—malignant glioma	1.17e-05	0.000204	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—STAT3—malignant glioma	1.16e-05	0.000202	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CG—malignant glioma	1.08e-05	0.000188	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—MYC—malignant glioma	1.08e-05	0.000188	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTT1—malignant glioma	1.06e-05	0.000185	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—EGFR—malignant glioma	1.05e-05	0.000184	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PPARG—malignant glioma	1.04e-05	0.000182	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—KRAS—malignant glioma	9.94e-06	0.000174	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PTGS1—malignant glioma	9.93e-06	0.000173	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CD—malignant glioma	9.47e-06	0.000165	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—BCHE—malignant glioma	9.23e-06	0.000161	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—PIK3CA—malignant glioma	9.14e-06	0.00016	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—SLC5A5—malignant glioma	9.12e-06	0.000159	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—TP53—malignant glioma	8.84e-06	0.000154	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CB—malignant glioma	8.26e-06	0.000144	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PTGS2—malignant glioma	8.18e-06	0.000143	CbGpPWpGaD
Argatroban—F2—Signaling Pathways—AKT1—malignant glioma	7.46e-06	0.00013	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—GSTP1—malignant glioma	7.34e-06	0.000128	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CAT—malignant glioma	7.15e-06	0.000125	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PTEN—malignant glioma	7.14e-06	0.000125	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—NCOR1—malignant glioma	6.75e-06	0.000118	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—CAV1—malignant glioma	5.5e-06	9.61e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—PIK3CA—malignant glioma	5.03e-06	8.79e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CG—malignant glioma	5.01e-06	8.75e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PPARG—malignant glioma	4.84e-06	8.45e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CD—malignant glioma	4.4e-06	7.69e-05	CbGpPWpGaD
Argatroban—CYP3A5—Metabolism—AKT1—malignant glioma	4.11e-06	7.18e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CB—malignant glioma	3.84e-06	6.71e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PTGS2—malignant glioma	3.8e-06	6.64e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PTEN—malignant glioma	3.32e-06	5.8e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.34e-06	4.09e-05	CbGpPWpGaD
Argatroban—CYP3A4—Metabolism—AKT1—malignant glioma	1.91e-06	3.34e-05	CbGpPWpGaD
